(RI) Pernod Ricard S.A. - Ratings and Ratios
Whiskey, Vodka, Gin, Rum, Liqueur, Champagne, Tequila, Mezcal, Aperitif
Description: RI Pernod Ricard S.A.
Pernod Ricard S.A. is a leading global spirits company with a diverse portfolio of premium brands across various categories, including whiskey, vodka, gin, rum, and champagne. The companys brand portfolio is valued for its quality and heritage, with iconic brands such as Absolut, Chivas, and The Glenlivet. With a presence in over 160 markets worldwide, Pernod Ricards global reach and scale enable it to capitalize on emerging trends and consumer preferences.
From a financial perspective, Pernod Ricards market capitalization stands at approximately €23.5 billion, with a forward price-to-earnings ratio of 13.26, indicating a relatively attractive valuation compared to its historical average. The companys return on equity (ROE) is around 10.40%, suggesting a stable and profitable business model. Additionally, Pernod Ricards dividend yield is an important consideration, as the company has a history of paying consistent dividends to shareholders.
Key performance indicators (KPIs) to monitor Pernod Ricards performance include revenue growth, gross margin expansion, and operating margin improvement. The companys ability to drive growth through innovation, brand investment, and geographic expansion will be crucial in delivering long-term value to shareholders. Other important metrics include the companys net debt-to-equity ratio, cash flow generation, and return on capital employed (ROCE). By analyzing these KPIs, investors can gain a deeper understanding of Pernod Ricards financial health, competitive position, and growth prospects.
From an operational perspective, Pernod Ricards success will depend on its ability to navigate the complex and evolving landscape of the global spirits industry. Key trends to watch include the rise of premiumization, the growth of e-commerce, and shifting consumer preferences towards low-ABV and non-alcoholic beverages. Pernod Ricards diversified brand portfolio and global reach position it well to capitalize on these trends, but the company must continue to innovate and adapt to changing market conditions.
RI Stock Overview
| Market Cap in USD | 26,889m |
| Sub-Industry | Distillers & Vintners |
| IPO / Inception |
RI Stock Ratings
| Growth Rating | -70.1% |
| Fundamental | 58.9% |
| Dividend Rating | 69.7% |
| Return 12m vs S&P 500 | -36.5% |
| Analyst Rating | - |
RI Dividends
| Dividend Yield 12m | 5.01% |
| Yield on Cost 5y | 3.80% |
| Annual Growth 5y | 12.06% |
| Payout Consistency | 96.6% |
| Payout Ratio | 24.9% |
RI Growth Ratios
| Growth Correlation 3m | 74.4% |
| Growth Correlation 12m | -76.6% |
| Growth Correlation 5y | -50.8% |
| CAGR 5y | -18.25% |
| CAGR/Max DD 3y | -0.31 |
| CAGR/Mean DD 3y | -0.60 |
| Sharpe Ratio 12m | -2.37 |
| Alpha | -46.18 |
| Beta | 0.986 |
| Volatility | 28.59% |
| Current Volume | 400.6k |
| Average Volume 20d | 393.2k |
| Stop Loss | 87.7 (-3%) |
| Signal | -0.73 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.11b TTM) > 0 and > 6% of Revenue (6% = 1.20b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 0.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.43% (prev 54.86%; Δ -25.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 1.84b <= Net Income 2.11b (YES >=105%, WARN >=100%) |
| Net Debt (10.76b) to EBITDA (5.02b) ratio: 2.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (252.1m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 59.44% (prev 59.93%; Δ -0.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.64% (prev 29.63%; Δ 23.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.90 (EBITDA TTM 5.02b / Interest Expense TTM 742.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.69
| (A) 0.16 = (Total Current Assets 12.36b - Total Current Liabilities 6.45b) / Total Assets 37.08b |
| (B) 0.03 = Retained Earnings (Balance) 1.19b / Total Assets 37.08b |
| (C) 0.11 = EBIT TTM 4.38b / Avg Total Assets 38.13b |
| (D) 0.73 = Book Value of Equity 15.21b / Total Liabilities 20.85b |
| Total Rating: 2.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.86
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.92% = 1.46 |
| 3. FCF Margin 5.43% = 1.36 |
| 4. Debt/Equity 1.07 = 1.96 |
| 5. Debt/Ebitda 3.23 = -2.06 |
| 6. ROIC - WACC 5.13% = 6.42 |
| 7. RoE 13.23% = 1.10 |
| 8. Rev. Trend -30.76% = -1.54 |
| 9. Rev. CAGR 0.49% = 0.06 |
| 10. EPS Trend -16.09% = -0.40 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of RI shares?
Over the past week, the price has changed by -4.90%, over one month by -6.42%, over three months by +4.48% and over the past year by -24.95%.
Is Pernod Ricard S.A. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RI is around 81.45 EUR . This means that RI is currently overvalued and has a potential downside of -9.92%.
Is RI a buy, sell or hold?
What are the forecasts/targets for the RI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109.8 | 21.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 89.3 | -1.2% |
RI Fundamental Data Overview
Market Cap EUR = 22.93b (22.93b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 1.83b EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 20.7385
P/E Forward = 13.2275
P/S = 2.0925
P/B = 1.3755
P/EG = 1.1996
Beta = 0.494
Revenue TTM = 20.07b EUR
EBIT TTM = 4.38b EUR
EBITDA TTM = 5.02b EUR
Long Term Debt = 14.40b EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.81b EUR (from shortTermDebt, last quarter)
Debt = 16.21b EUR (Calculated: Short Term 1.81b + Long Term 14.40b)
Net Debt = 10.76b EUR (from netDebt column, last quarter)
Enterprise Value = 37.32b EUR (22.93b + Debt 16.21b - CCE 1.83b)
Interest Coverage Ratio = 5.90 (Ebit TTM 4.38b / Interest Expense TTM 742.5m)
FCF Yield = 2.92% (FCF TTM 1.09b / Enterprise Value 37.32b)
FCF Margin = 5.43% (FCF TTM 1.09b / Revenue TTM 20.07b)
Net Margin = 10.49% (Net Income TTM 2.11b / Revenue TTM 20.07b)
Gross Margin = 59.44% ((Revenue TTM 20.07b - Cost of Revenue TTM 8.14b) / Revenue TTM)
Tobins Q-Ratio = 2.45 (Enterprise Value 37.32b / Book Value Of Equity 15.21b)
Interest Expense / Debt = 1.61% (Interest Expense 260.5m / Debt 16.21b)
Taxrate = 25.51% (574.0m / 2.25b)
NOPAT = 3.26b (EBIT 4.38b * (1 - 25.51%))
Current Ratio = 1.92 (Total Current Assets 12.36b / Total Current Liabilities 6.45b)
Debt / Equity = 1.07 (Debt 16.21b / last Quarter total Stockholder Equity 15.21b)
Debt / EBITDA = 3.23 (Net Debt 10.76b / EBITDA 5.02b)
Debt / FCF = 14.86 (Debt 16.21b / FCF TTM 1.09b)
Total Stockholder Equity = 15.92b (last 4 quarters mean)
RoA = 5.68% (Net Income 2.11b, Total Assets 37.08b )
RoE = 13.23% (Net Income TTM 2.11b / Total Stockholder Equity 15.92b)
RoCE = 14.44% (Ebit 4.38b / (Equity 15.92b + L.T.Debt 14.40b))
RoIC = 11.28% (NOPAT 3.26b / Invested Capital 28.92b)
WACC = 6.15% (E(22.93b)/V(39.15b) * Re(9.65%)) + (D(16.21b)/V(39.15b) * Rd(1.61%) * (1-Tc(0.26)))
Shares Correlation 3-Years: -41.32 | Cagr: -0.33%
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.40% ; FCFE base≈963.8m ; Y1≈1.19b ; Y5≈2.03b
Fair Price DCF = 103.1 (DCF Value 25.95b / Shares Outstanding 251.7m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: -30.76 | Revenue CAGR: 0.49%
Rev Growth-of-Growth: -59.59
EPS Correlation: -16.09 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 329.8